Business Wire

Takeda Announces New Assignments of Directors

Share

Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the Audit and Supervisory Committee meeting, following the 148th Ordinary Meeting of Shareholders, held in Osaka today.

Takeda's Board of Directors has 11 members serving as external directors out of a total of 14 members, helping to ensure transparency and objectivity. An external director will continue to chair the Board of Directors. The Audit and Supervisory Committee, the Nomination Committee and the Compensation Committee will be composed solely of external directors including their chairs.

Takeda highly values strong, independent governance and its Board of Directors helps to ensure that all decisions and actions are in the best interests of global stakeholders and aligned with the company’s values. This robust corporate governance model has been, and will continue to be, critical to Takeda's success.

Details of the new assignments are as follows:

1. New Assignment of Directors Who Are Not Audit and Supervisory Committee Members (Effective June 26, 2024)

Name

Category

Role

Christophe Weber

Internal

Existing

Representative Director, President & Chief Executive Officer

Milano Furuta

Internal

New

Director, Chief Financial Officer

Andrew Plump

Internal

Existing

Director, President, Research & Development

Masami Iijima

External

Existing

External Director, Chair of the Board Meeting

Ian Clark

External

Existing

External Director

Steven Gillis

External

Existing

External Director

Emiko Higashi

External

New

External Director

John Maraganore

External

Existing

External Director

Michel Orsinger

External

Existing

External Director

Miki Tsusaka

External

Existing

External Director

2. Directors Who Are Audit and Supervisory Committee Members (Effective June 26, 2024)

Name

Category

Role

Koji Hatsukawa

External

Existing

External Director, Head of Audit and Supervisory Committee

Jean-Luc Butel

External

New

External Director, Audit and Supervisory Committee Member

Yoshiaki Fujimori

External

Existing

External Director, Audit and Supervisory Committee Member

Kimberly A. Reed

External

Existing

External Director, Audit and Supervisory Committee Member

3. New Assignment of Nomination Committee and Compensation Committee Members (Effective June 26, 2024)

Nomination committee:
Masami Iijima (Chairperson), Steven Gillis, Emiko Higashi, Michel Orsinger, Jean-Luc Butel, and Yoshiaki Fujimori
(Observer: Christophe Weber)

Compensation committee:
Emiko Higashi (Chairperson), John Maraganore, Michel Orsinger, and Kimberly A. Reed

About Takeda
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.

Important Notice
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this press release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.

The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.

Forward-Looking Statements
This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects”, “forecasts”, “outlook” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240619545549/en/

Contacts

Media Contacts:
Japanese Media
Shoko Honda
shoko.honda@takeda.com
+81 (0) 70-2687-3620

U.S. and International Media
Brendan Jennings
brendan.jennings@takeda.com
+81 (0) 80-2705-8259

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

the International Film Criticism Conference Is Launched in Riyadh8.11.2024 18:06:00 CET | Press Release

The Saudi Film Commission announced the commencement of the second edition of the International Film Criticism Conference in Riyadh, running from November 6 to 10, 2024. The conference is distinguished by a vast presence of international filmmakers, critics, and cinephiles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108289069/en/ The International Film Criticism Conference is launched in Riyadh (Photo: AETOSWire) The second edition of the Film Criticism Conference is held under the theme "Sound in Cinema", to explore the various impacts of sound on the film experience and its influence on the film industry. The discussions will cover different elements such as film scores, sound effects, and nature sounds. The conference will also include workshops, film screenings, and interactive exhibits. The opening ceremony started with an introductory video about the conference, its objectives, and past achievements, followed by

Panini S.p.A. Launches Expanded BioCred Solution Suite in Europe at Future Identity Festival8.11.2024 16:00:00 CET | Press Release

Panini S.p.A., a global leader in payments technology and identity solutions, announces the European launch of its BioCred solution suite at Future Identity Festival, in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108392625/en/ Securing the Future, One Identity at a Time. (Photo: Business Wire) BioCred is now available on cloud infrastructure, giving rise to the new BioCred CloudServ, which represents the first step toward a hardware-agnostic solution. As of today, BioCred CloudServ is accessible via the mobile device BioCred SecureTab, the latest addition to the Panini BioCred family of devices, creating a seamlessly integrated flow and delivering a comprehensive, secure identity solution. This turnkey solution, which was presented for the first time at Identity Week America in September, offers a wide range of authentication and verification functions, including the patented Panini BioCred method into a s

ITEN to Launch the Industrial-Scale Production of Its All-Solid-State Battery Powency Product Family8.11.2024 09:00:00 CET | Press Release

Electronica 2024 Trade Fair--ITEN, a pioneer in the development and production of solid-state batteries for electronics markets, today announced the production launch of its new Powency family of rechargeable Li-ion batteries. The new family consists of high-power density batteries, including for now the PWY0150S battery, available in pre-production, and the PWY0250S battery, available as engineering samples. Those first Powency batteries respectively have a capacity of 150µAh and 250µAh. The Powency product family, which is manufactured at the ITEN facility in France, is a testament to the demonstration of ITEN's technological and industrial leadership in the field of solid-state batteries. ITEN will participate in the Electronica trade show in Munich from November 12 to 15, 2024 (Hall B4 - Stand E05) to showcase both PWY0150S and PWY0250S. Powency PWY0150S and PWY0250S, solid-state energy storage in an unmatched form factor The Powency PWS0150S and PWS0250S batteries are designed to

FPT Named Disruptor In HFS Horizons: IoT Service Providers, 20248.11.2024 06:53:00 CET | Press Release

Global IT firm FPT, through its subsidiary FPT Software, has been recognized as a Disruptor in HFS Research Horizons report: IoT Service Providers, 2024. This marks the inaugural inclusion of FPT in this prestigious industry assessment, demonstrating its Internet of Things (IoT) capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241107263712/en/ (Graphic: Business Wire) The report examines the IoT service capabilities of 23 service providers in the evolving IoT landscape in the age of the Generative Enterprise. It focuses on the supply side, detailing the service providers’ strengths and growth opportunities. FPT’s IoT capabilities encompass a comprehensive range of services designed to address diverse industry needs, from smart homes and healthcare to logistics and manufacturing. With over 3,000 IoT engineers and a portfolio of more than 500 projects, FPT delivers end-to-end IoT solutions, including hardware desig

Analyze Contracts Like a Lawyer - Wordsmith’s First Pass Unlocks Legal Insight for Everyone7.11.2024 23:54:00 CET | Press Release

“Contracts often hold up business because legal teams are stretched too thin,” said Ross McNairn, CEO of Wordsmith. “First Pass allows anyone from the legal, commercial or other teams to quickly identify risks and key terms, helping move things forward.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241108164624/en/ Wordsmith's First Pass lets you review contracts in minutes, not hours. (Graphic: Business Wire) This is a glimpse at the future of legal AI agents. Taking a very specific task end-to-end and making it trivial for anyone to trigger. Try It for Free Users can access First Pass for free by creating an account at wordsmith.ai and then uploading the relevant agreement to the web, or simply email standard agreements—like NDAs—to nda@wordsmith.ai. Over the coming weeks, Wordsmith will be expanding this to many other agreement types. End-to-End AI Analysis—More Than Just Contracting What makes First Pass revolutionary

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye